Katherine Bock

Katherine Bock has over 15 years of experience in the life sciences industry. Before joining Adverum, Ms. Bock led corporate development and investor relations at Nevro, a medical device company focused on improving the quality of life for people living with chronic pain, and also served as chief of staff for the chief executive officer. She helped execute Nevro’s successful initial public offering in 2014, as the first medical device company to price above their range since 2007, and helped lead subsequent financings, including the largest medtech follow-on in over 10 years and a convertible raise. Before Nevro, she worked at Lazard as an associate in the healthcare investment banking group, where she focused on M&A advisory roles and capital market transactions. Previously, Ms. Bock worked at Genentech as a market planning manager associate in the competitive intelligence group, where she was responsible for assessing the competitive landscape for pipeline products. Earlier in her career, Ms. Bock conducted biotechnology research at Genentech in the small molecule translational oncology group and in Corgentech’s oncology group. Ms. Bock earned a B.S. in Applied Mathematics at San Francisco State University and an M.B.A. from The Wharton School at the University of Pennsylvania. She is also active in the community with the Board of the Northern California Chapter of the National Multiple Sclerosis Society as the former Treasurer.